6542-47-8 Usage
Uses
Used in Pharmaceutical Industry:
Nicotinic acid, 6-formyl(8CI) is used as a pharmaceutical intermediate for the synthesis of various compounds with potential therapeutic applications. Its unique structure may allow for the development of new drugs with improved efficacy or reduced side effects.
Used in Research and Development:
In the field of scientific research, Nicotinic acid, 6-formyl(8CI) serves as a valuable compound for studying the effects of structural modifications on the properties and functions of nicotinic acid and its derivatives. This can lead to a better understanding of the underlying mechanisms of action and the discovery of novel applications in medicine and other fields.
Used in Nutritional Supplements:
As a derivative of an essential nutrient, Nicotinic acid, 6-formyl(8CI) may be incorporated into nutritional supplements to support overall health and well-being. Its potential role in energy metabolism and other biological processes could offer additional benefits compared to traditional sources of vitamin B3.
Check Digit Verification of cas no
The CAS Registry Mumber 6542-47-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,5,4 and 2 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 6542-47:
(6*6)+(5*5)+(4*4)+(3*2)+(2*4)+(1*7)=98
98 % 10 = 8
So 6542-47-8 is a valid CAS Registry Number.
6542-47-8Relevant academic research and scientific papers
Disubstituted aryl and heteroaryl imines having retinoid-like biological activity
-
, (2008/06/13)
Compounds of the formula STR1 wherein the R 1 groups independently are hydrogen, lower alkyl, or two geminal R 1 groups jointly represent an oxo ( O) or a thio ( S) group; R 2 is hydrogen or lower alkyl, or halogen; M is or --N CR 4 -- or --R 4 C N-- where R 4 is hydrogen or lower alkyl; X is C(R 1) 2 ; Y is phenyl optionally substituted with an R 3 group which is lower alkyl or halogen; A is (CH 2) n where n is 0-5, lower branched chain alkyl, cycloalkyl, alkenyl, alkynyl; B is hydrogen, COOH or a pharmaceutically acceptable salt thereof, COOR 8, CONR 9 R 10, --CH 2 OH, CH 2OR 11, CH 2 OCOR 11, CHO, CH(OR 12) 2, CHOR 13 O, --COR 7, CR 7 (OR 12) 2, or CR 7 OR 13 O, where R 7 is an alkyl, cycloalkyl or alkenyl group containing 1 to 5 carbons, R 8 is an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or R 8 is phenyl or lower alkylphenyl, R 9 and R 10 independently are hydrogen, an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5-10 carbons, or phenyl or lower alkylphenyl, R 11 is lower alkyl, phenyl or lower alkylphenyl, R 12 is lower alkyl, and R 13 is divalent alkyl radical of 2-5 carbons have retinoid-like biological activity.
